Clinical Trial Update: High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of high-activity natural killer immunotherapy for metastases in nasopharyngeal cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• High-activity Natural Killer immunotherapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Metastatic Nasopharyngeal Cancer | Phase 1, Phase 2 | Status: COMPLETED